News About: Pharm. Industry
Trade deal to help Korean firms tap Indian market
A trade agreement with India is expected to help Korean medical device makers accelerate their inroads into Asia's third-largest economy and solidify their presence there, according to the Ministry of Health, Welfare ...
Baxter to produce A/H1N1 pandemic vaccine on large scale
Baxter International Inc. said on August 7 it completed production of its first commercial batches of C A/H1N1 pandemic vaccine in late July and is discussing plans for distribution with national health authorities to...
Dream Pharma signs exclusive license agreement with Addrenex
Dream Pharma, a division of Hanwha Group, said on August 4 that it signed an exclusive licensing agreement with the US-based Addrenex Pharmaceuticals to market a sustained-release formulation of Clonicel (clonidine hy...
Multinationals urge government to guarantee Korean doctors’ participation in foreign seminars
Foreign companies advised the Korea government to allow Korean doctors to take part in a variety of foreign congresses as part of scientific efforts to exchange information about new insights in drug development.
T...
Lee Jae-ho named executive director of BMS
BMS Korea said it has recently tapped Lee Jae-ho to become its executive director who will be responsible for taking charge of Cardiovascular & Metabolic Business Unit.
Lee, 46, obtained a bachelor degree in pharma...
M&As, restructuring to sweep pharmaceutical industry
The government’s tougher action against illegal rebates in the local pharmaceutical industry is making it harder for small- and medium-sized firms to do business.
Analysts expect a large number of mergers and acqu...
Steps sought to activate domestic biosimilar development
The establishment of a regulatory pathway for biosimilars will be the first step in creating a market pathway for biosimilars, according to the Korea Food and Drug Administration.
In an information session on July ...
Domestic pharmaceutical industry likely to lose momentum over rebate ban
Korean firms’ generic drugs are expected to lose steam once the government cracks down on pharmaceutical firms offering rebates starting August.
Experts said domestic manufacturers can no longer expect to live off ...
Pharmaceutical industry vows to root out illicit practices
The Korea Pharmaceutical Manufacturers Association pledged to improve unethical practices in the pharmaceutical industry at a special board of directors meeting held on July 30.
50 members of the KPMA discussed cou...
Rebate ban corners small drugmakers
A majority of small pharmaceutical firms are now agonizing over falling sales of their prescription drugs the government will be allowed to forcibly lower drug prices by up to 20 percent if their producers are found t...
